SBBC:CA:TSV-Simply Better Brands Corp (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 1.01

Change

-0.08 (-7.34)%

Market Cap

USD 0.10B

Volume

0.50M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
RX:CA Biosyent Inc.

+0.08 (+0.72%)

USD 0.14B
HASH:CA Simply Solventless Concentrate..

N/A

USD 0.07B
ZYUS:CA ZYUS Life Sciences Corporation

-0.05 (-5.56%)

USD 0.06B
LOVE:CA Cannara Biotech Inc

+0.01 (+1.32%)

USD 0.06B
DB:CA Decibel Cannabis Company Inc

N/A

USD 0.04B
LSL:CA LSL Pharma Group Inc.

-0.02 (-3.61%)

USD 0.04B
ROMJ:CA Rubicon Organics Inc

N/A

USD 0.02B
PCLO:CA Pharmacielo Ltd

N/A

USD 0.01B
ELXR:CA Elixxer Ltd

N/A

USD 0.01B
VM:CA Voyageur Pharmaceuticals Ltd

N/A

USD 0.01B

ETFs Containing SBBC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.34% 13% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.34% 13% F 13% F
Trailing 12 Months  
Capital Gain 380.95% 89% A- 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 380.95% 89% A- 98% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.54% 58% F 52% F
Dividend Return 0.54% 58% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 94.30% 26% F 31% F
Risk Adjusted Return 0.57% 58% F 51% F
Market Capitalization 0.10B 95% A 92% A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.